Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study

Background and aim: Cardiovascular risk-prediction models are efficient primary prevention tools to detect high-risk individuals. The study aims to use three tools to estimate the 10-year risk of developing cardiovascular disease (CVD) and investigate their agreement in an Iranian adult population....

Full description

Bibliographic Details
Main Authors: Mahdieh Momayyezi, Reyhane Sefidkar, Hossein Fallahzadeh
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023076041
_version_ 1797646562360295424
author Mahdieh Momayyezi
Reyhane Sefidkar
Hossein Fallahzadeh
author_facet Mahdieh Momayyezi
Reyhane Sefidkar
Hossein Fallahzadeh
author_sort Mahdieh Momayyezi
collection DOAJ
description Background and aim: Cardiovascular risk-prediction models are efficient primary prevention tools to detect high-risk individuals. The study aims to use three tools to estimate the 10-year risk of developing cardiovascular disease (CVD) and investigate their agreement in an Iranian adult population. Methods: The current cross-sectional study was carried out on 8569 adults between 35 and 70 who participated in the first phase of the Shahedieh cohort study in Yazd, Iran, and were free of CVDs (cardiac ischemia or myocardial infarction or stroke). World Health Organization/International Society of Hypertension (WHO/ISH) chart, Laboratory-Based (LB) and Non-Laboratory-Based (NLB) Framingham Risk Score (FRS) were used to predict the 10-year risk of developing CVD. The agreement across tools was determined by Kappa. Results: WHO/ISH chart indicated the highest prevalence of low CVD risk for males (96.10%) and females (96.50%), while NLB Framingham had the highest prevalence of high CVD risk for males (19.40%) and females (5.30%). In total, there was substantial agreement between both FRS models (Kappa = o.70), while there was a slight agreement between WHO/ISH and both FRS tools. For under 60 years males and females, substantial agreements were observed between FRS methods (kappa = 0.73 and kappa = 0.68). For males and females over 60 years, this agreement was moderate and substantial, respectively (kappa = 0.54 and kappa = 0.64). WHO/ISH and LB Framingham model had substantial agreement for over 60 years females (kappa = 0.61). Conclusions: Framingham models classified more participants in the high-risk category than WHO/ISH. Due to the lethality of CVDs, categorizing individuals based on FRS can ensure that most of the real high-risk people are detected. Remarkable agreement between FRS methods in all sex-age groups suggested using the NLB Framingham model as a primary screening tool, especially in a shortage of resources condition.
first_indexed 2024-03-11T15:03:24Z
format Article
id doaj.art-10da8237a2d74118ae5425941132bcc4
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-11T15:03:24Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-10da8237a2d74118ae5425941132bcc42023-10-30T06:05:56ZengElsevierHeliyon2405-84402023-10-01910e20396Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort StudyMahdieh Momayyezi0Reyhane Sefidkar1Hossein Fallahzadeh2Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, IranCenter for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; Corresponding author.Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, IranBackground and aim: Cardiovascular risk-prediction models are efficient primary prevention tools to detect high-risk individuals. The study aims to use three tools to estimate the 10-year risk of developing cardiovascular disease (CVD) and investigate their agreement in an Iranian adult population. Methods: The current cross-sectional study was carried out on 8569 adults between 35 and 70 who participated in the first phase of the Shahedieh cohort study in Yazd, Iran, and were free of CVDs (cardiac ischemia or myocardial infarction or stroke). World Health Organization/International Society of Hypertension (WHO/ISH) chart, Laboratory-Based (LB) and Non-Laboratory-Based (NLB) Framingham Risk Score (FRS) were used to predict the 10-year risk of developing CVD. The agreement across tools was determined by Kappa. Results: WHO/ISH chart indicated the highest prevalence of low CVD risk for males (96.10%) and females (96.50%), while NLB Framingham had the highest prevalence of high CVD risk for males (19.40%) and females (5.30%). In total, there was substantial agreement between both FRS models (Kappa = o.70), while there was a slight agreement between WHO/ISH and both FRS tools. For under 60 years males and females, substantial agreements were observed between FRS methods (kappa = 0.73 and kappa = 0.68). For males and females over 60 years, this agreement was moderate and substantial, respectively (kappa = 0.54 and kappa = 0.64). WHO/ISH and LB Framingham model had substantial agreement for over 60 years females (kappa = 0.61). Conclusions: Framingham models classified more participants in the high-risk category than WHO/ISH. Due to the lethality of CVDs, categorizing individuals based on FRS can ensure that most of the real high-risk people are detected. Remarkable agreement between FRS methods in all sex-age groups suggested using the NLB Framingham model as a primary screening tool, especially in a shortage of resources condition.http://www.sciencedirect.com/science/article/pii/S2405844023076041Cardiovascular diseasesFramingham risk scoresWHO/ISH risk chartCardiovascular riskRisk assessment
spellingShingle Mahdieh Momayyezi
Reyhane Sefidkar
Hossein Fallahzadeh
Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study
Heliyon
Cardiovascular diseases
Framingham risk scores
WHO/ISH risk chart
Cardiovascular risk
Risk assessment
title Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study
title_full Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study
title_fullStr Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study
title_full_unstemmed Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study
title_short Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study
title_sort agreement between ten years cardiovascular disease risk assessment tools an application to iranian population in shahedieh cohort study
topic Cardiovascular diseases
Framingham risk scores
WHO/ISH risk chart
Cardiovascular risk
Risk assessment
url http://www.sciencedirect.com/science/article/pii/S2405844023076041
work_keys_str_mv AT mahdiehmomayyezi agreementbetweentenyearscardiovasculardiseaseriskassessmenttoolsanapplicationtoiranianpopulationinshahediehcohortstudy
AT reyhanesefidkar agreementbetweentenyearscardiovasculardiseaseriskassessmenttoolsanapplicationtoiranianpopulationinshahediehcohortstudy
AT hosseinfallahzadeh agreementbetweentenyearscardiovasculardiseaseriskassessmenttoolsanapplicationtoiranianpopulationinshahediehcohortstudy